Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue

Molecular Oncology

Volumn 8, Issue 3, 2014, Pages 717-727

  Aktas, Bilge ^a   Sun, Hongxia ^b   Yao, Hui ^b   Shi, Weiwei ^a   Hubbard, Rebekah ^b   Zhang, Ya ^b   Jiang, Tingting ^a   Ononye, Sophia N ^a   Wali, Vikram B ^a   Pusztai, Lajos ^a   Symmans, W Fraser ^b   Hatzis, Christos ^a  

^a YALE CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cold ischemia; Genomic index; Hypoxia; Ischemic stress index; Microarrays; RNAlater; Snap freezing

Indexed keywords

MESSENGER RNA;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER TISSUE; CELL CYCLE REGULATION; CLINICAL ARTICLE; COLD ISCHEMIA; COLD STRESS; CORRELATION COEFFICIENT; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN PROCESSING; ROOM TEMPERATURE; VERY ELDERLY; BREAST TUMOR; CELL HYPOXIA; COLD; COMPLICATION; CRYOPRESERVATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; ISCHEMIA; PROCEDURES; TISSUE PRESERVATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL HYPOXIA; COLD TEMPERATURE; CRYOPRESERVATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; ISCHEMIA; MIDDLE AGED; RNA, MESSENGER; TISSUE PRESERVATION;

EID: 84899483951     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2014.02.002     Document Type: Article

References (46)

1. Abdullah-Sayani A., Bueno-de-Mesquita J.M., van de Vijver M.J. Technology Insight: tuning into the genetic orchestra using microarrays-limitations of DNA microarrays in clinical practice. Nat. Clin. Pract. Oncol. 2006, 3:501-516.
2. Bando Y., Tsukamoto Y., Katayama T., Ozawa K., Kitao Y., Hori O., Stern D.M., Yamauchi A., Ogawa S. ORP150/HSP12A protects renal tubular epithelium from ischemia-induced cell death. FASEB J. 2004, 18:1401-1403.
3. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J.R. Stat. Soc. Ser. B 1995, 57:289-300.
4. Borgan E., Navon R., Vollan H.K., Schlichting E., Sauer T., Yakhini Z., Lingjaerde O.C., Sorlie T., Borresen-Dale A.L. Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue. Mol. Oncol. 2011, 5:564-576.
5. Costa M.J., Wu X., Cuervo H., Srinivasan R., Bechis S.K., Cheang E., Marjanovic O., Gridley T., Cvetic C.A., Wang R.A. Notch4 is required for tumor onset and perfusion. Vasc. Cell 2013, 5:7.
6. De Cecco L., Musella V., Veneroni S., Cappelletti V., Bongarzone I., Callari M., Valeri B., Pierotti M.A., Daidone M.G. Impact of biospecimens handling on biomarker research in breast cancer. BMC Cancer 2009, 9:409.
7. Duan J., Shi J., Ge X., Dolken L., Moy W., He D., Shi S., Sanders A.R., Ross J., Gejman P.V. Genome-wide survey of interindividual differences of RNA stability in human lymphoblastoid cell lines. Sci. Rep. 2013, 3:1318.
8. Fleige S., Pfaffl M.W. RNA integrity and the effect on the real-time qRT-PCR performance. Mol. Aspects Med. 2006, 27:126-139.
9. Fukuyama R., Niculaita R., Ng K.P., Obusez E., Sanchez J., Kalady M., Aung P.P., Casey G., Sizemore N. Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription. Oncogene 2008, 27:6044-6055.
10. Gee J.M., Willsher P.C., Kenny F.S., Robertson J.F., Pinder S.E., Ellis I.O., Nicholson R.I. Endocrine response and resistance in breast cancer: a role for the transcription factor Fos. Int. J. Cancer 1999, 84:54-61.
11. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., Hornik K., Hothorn T., Huber W., Iacus S., Irizarry R., Leisch F., Li C., Maechler M., Rossini A.J., Sawitzki G., Smith C., Smyth G., Tierney L., Yang J.Y., Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5:R80.
12. Hammond M.E., Hayes D.F., Dowsett M., Allred D.C., Hagerty K.L., Badve S., Fitzgibbons P.L., Francis G., Goldstein N.S., Hayes M., Hicks D.G., Lester S., Love R., Mangu P.B., McShane L., Miller K., Osborne C.K., Paik S., Perlmutter J., Rhodes A., Sasano H., Schwartz J.N., Sweep F.C., Taube S., Torlakovic E.E., Valenstein P., Viale G., Visscher D., Wheeler T., Williams R.B., Wittliff J.L., Wolff A.C. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J.Clin. Oncol. 2010, 28:2784-2795.
13. Han J., Hendzel M.J., Allalunis-Turner J. Notch signaling as a therapeutic target for breast cancer treatment?. Breast Cancer Res. 2011, 13:210.
14. Hatzis C., Sun H., Yao H., Hubbard R.E., Meric-Bernstam F., Babiera G.V., Wu Y., Pusztai L., Symmans W.F. Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers. J.Natl. Cancer Inst. 2011, 103:1871-1883.
15. Hiyama A., Skubutyte R., Markova D., Anderson D.G., Yadla S., Sakai D., Mochida J., Albert T.J., Shapiro I.M., Risbud M.V. Hypoxia activates the notch signaling pathway in cells of the intervertebral disc: implications in degenerative disc disease. Arthritis Rheum. 2011, 63:1355-1364.
16. Ioannidis J.P. Is molecular profiling ready for use in clinical decision making?. Oncologist 2007, 12:301-311.
17. Kohonen-Corish M.R., Sigglekow N.D., Susanto J., Chapuis P.H., Bokey E.L., Dent O.F., Chan C., Lin B.P., Seng T.J., Laird P.W., Young J., Leggett B.A., Jass J.R., Sutherland R.L. Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer. Oncogene 2007, 26:4435-4441.
18. Li X., Deavers M.T., Guo M., Liu P., Gong Y., Albarracin C.T., Middleton L.P., Huo L. The effect of prolonged cold ischemia time on estrogen receptor immunohistochemistry in breast cancer. Mod. Pathol. 2013, 26:71-78.
19. Lin D.W., Coleman I.M., Hawley S., Huang C.Y., Dumpit R., Gifford D., Kezele P., Hung H., Knudsen B.S., Kristal A.R., Nelson P.S. Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis. J.Clin. Oncol. 2006, 24:3763-3770.
20. Luo W., Friedman M.S., Shedden K., Hankenson K.D., Woolf P.J. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinform. 2009, 10:161.
21. Ma D., Dong X., Zang S., Ma R., Zhao P., Guo D., Dai J., Chen F., Ye J., Ji C. Aberrant expression and clinical correlation of Notch signaling molecules in breast cancer of Chinese population. Asia Pac. J. Clin. Oncol. 2011, 7:385-391.
22. Michaud C.L., Foran D.R. Simplified field preservation of tissues for subsequent DNA analyses. J.Forensic Sci. 2011, 56:846-852.
23. Mihaly Z., Kormos M., Lanczky A., Dank M., Budczies J., Szasz M.A., Gyorffy B. A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer. Breast Cancer Res. Treat 2013, 140:219-232.
24. Murphy P.A., Kim T.N., Lu G., Bollen A.W., Schaffer C.B., Wang R.A. Notch4 normalization reduces blood vessel size in arteriovenous malformations. Sci. Transl Med. 2012, 4:117-118.
25. Musella V., Verderio P., Reid J.F., Pizzamiglio S., Gariboldi M., Callari M., Milione M., De Cecco L., Veneroni S., Pierotti M.A., Daidone M.G. Effects of warm ischemic time on gene expression profiling in colorectal cancer tissues and normal mucosa. PLoS One 2013, 8:e53406.
26. Nathaniel T.I., Otukonyong E., Abdellatif A., Soyinka J.O. Effect of hypoxia on metabolic rate, core body temperature, and c-fos expression in the naked mole rat. Int. J. Dev. Neurosci. 2012, 30:539-544.
27. Neumeister V.M., Anagnostou V., Siddiqui S., England A.M., Zarrella E.R., Vassilakopoulou M., Parisi F., Kluger Y., Hicks D.G., Rimm D.L. Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues. J.Natl. Cancer Inst. 2012, 104:1815-1824.
28. Pangon L., Sigglekow N.D., Larance M., Al-Sohaily S., Mladenova D.N., Selinger C.I., Musgrove E.A., Kohonen-Corish M.R. The "mutated in colorectal Cancer" protein is a novel target of the UV-induced DNA damage checkpoint. Genes Cancer 2010, 1:917-926.
29. Pounds S., Cheng C. Improving false discovery rate estimation. Bioinformatics 2004, 20:1737-1745.
30. R Core Team R: A Language and Environment for Statistical Computing 2013, R Foundation for Statistical Computing, Vienna, Austria, URL: http://www.R-project.org/.
31. Reedijk M. Notch signaling and breast cancer. Adv. Exp. Med. Biol. 2012, 727:241-257.
32. Reis-Filho J.S., Tutt A.N. Triple negative tumours: a critical review. Histopathology 2008, 52:108-118.
33. Schroeder A., Mueller O., Stocker S., Salowsky R., Leiber M., Gassmann M., Lightfoot S., Menzel W., Granzow M., Ragg T. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol. Biol. 2006, 7:3.
34. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3. Article3.
35. Smyth G.K., Michaud J., Scott H.S. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 2005, 21:2067-2075.
36. Sotiriou C., Wirapati P., Loi S., Harris A., Fox S., Smeds J., Nordgren H., Farmer P., Praz V., Haibe-Kains B., Desmedt C., Larsimont D., Cardoso F., Peterse H., Nuyten D., Buyse M., Van de Vijver M.J., Bergh J., Piccart M., Delorenzi M. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J.Natl. Cancer Inst. 2006, 98:262-272.
37. Sparano J.A., Solin L.J. Defining the clinical utility of gene expression assays in breast cancer: the intersection of science and art in clinical decision making. J.Clin. Oncol. 2010, 28:1625-1627.
38. Speiser J., Foreman K., Drinka E., Godellas C., Perez C., Salhadar A., Ersahin C., Rajan P. Notch-1 and Notch-4 biomarker expression in triple-negative breast cancer. Int. J. Surg. Pathol. 2012, 20:139-145.
39. Staff S., Kujala P., Karhu R., Rokman A., Ilvesaro J., Kares S., Isola J. Preservation of nucleic acids and tissue morphology in paraffin-embedded clinical samples: comparison of five molecular fixatives. J.Clin. Pathol. 2013, 66:807-810.
40. Stojadinovic A., Hooke J.A., Shriver C.D., Nissan A., Kovatich A.J., Kao T.C., Ponniah S., Peoples G.E., Moroni M. HYOU1/Orp150 expression in breast cancer. Med. Sci. Monit. 2007, 13:BR231-239.
41. Symmans F.W., Hatzis C., Sotiriou C., Andre F., Peintinger F., Regitnig P., Daxenbichler G., Desmedt C., Domont J., Marth C., Delaloge S., Bauernhofer T., Valero V., Booser D., Hortobagyi G.N., Pusztai L. Genomic index of sensitivity to endoccrine therapy for breast cancer. J.Clin. Oncol. 2010, 28:4111-4119.
42. Webster M.J. Tissue preparation and banking. Prog. Brain Res. 2006, 158:3-14.
43. Wolff A.C., Hammond M.E., Schwartz J.N., Hagerty K.L., Allred D.C., Cote R.J., Dowsett M., Fitzgibbons P.L., Hanna W.M., Langer A., McShane L.M., Paik S., Pegram M.D., Perez E.A., Press M.F., Rhodes A., Sturgeon C., Taube S.E., Tubbs R., Vance G.H., van de Vijver M., Wheeler T.M., Hayes D.F., American Society of Clinical, O., College of American, P American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J.Clin. Oncol. 2007, 25:118-145.
44. Wong V., Wang D.Y., Warren K., Kulkarni S., Boerner S., Done S.J., Leong W.L. The effects of timing of fine needle aspiration biopsies on gene expression profiles in breast cancers. BMC Cancer 2008, 8:277.
45. Wu J.Y., Vlastos A.T., Pelte M.F., Caligo M.A., Bianco A., Krause K.H., Laurent G.J., Irminger-Finger I. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis. Int. J. Cancer 2006, 118:1215-1226.
46. Yildiz-Aktas I.Z., Dabbs D.J., Bhargava R. The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma. Mod. Pathol. 2012, 25:1098-1105.